| Aug 5 |
Google's search monopoly, El-Erian talks the Fed: Market Domination
|
| Aug 5 |
Investing in biotech outside of weight-loss drugs
|
| Aug 5 |
Regeneron (REGN) Q2 Earnings Gain From Eylea HD, Dupixent
|
| Aug 3 |
Is Regeneron Pharmaceuticals Due for a Stock Split?
|
| Aug 2 |
Alnylam (ALNY) Up as Q2 Earnings Beat on Collaboration Revenues
|
| Aug 2 |
Regeneron's Robust Pipeline And Financial Health Signal Continued Growth
|
| Aug 2 |
Q2 2024 Regeneron Pharmaceuticals Inc Earnings Call
|
| Aug 1 |
Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs
|
| Aug 1 |
Defensive Sectors Breakout: 3 Stocks to Buy Now for Protection
|
| Aug 1 |
Regeneron Pharmaceuticals, Inc. (REGN) Q2 2024 Earnings Call Transcript
|
